Lisa Walter
Stock Analyst at RBC Capital
(1.05)
# 2,812
Out of 4,361 analysts
68
Total ratings
37.9%
Success rate
-2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGTX MeiraGTx Holdings | Maintained: Buy | $24 → $25 | $9.24 | +170.56% | 7 | May 14, 2026 | |
| EYPT EyePoint | Maintained: Buy | $39 → $37 | $12.53 | +195.29% | 7 | May 7, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $142 | $92.17 | +54.06% | 1 | May 7, 2026 | |
| FDMT 4D Molecular Therapeutics | Maintained: Buy | $35 | $9.27 | +277.56% | 24 | May 7, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $707 → $701 | $540.05 | +29.80% | 10 | May 6, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $30 → $34 | $15.87 | +114.24% | 5 | May 6, 2026 | |
| OCUL Ocular Therapeutix | Maintained: Buy | $30 | $8.31 | +261.01% | 9 | May 5, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintained: Buy | $136 → $137 | $84.35 | +62.42% | 5 | May 5, 2026 |
MeiraGTx Holdings
May 14, 2026
Maintained: Buy
Price Target: $24 → $25
Current: $9.24
Upside: +170.56%
EyePoint
May 7, 2026
Maintained: Buy
Price Target: $39 → $37
Current: $12.53
Upside: +195.29%
Mirum Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $142
Current: $92.17
Upside: +54.06%
4D Molecular Therapeutics
May 7, 2026
Maintained: Buy
Price Target: $35
Current: $9.27
Upside: +277.56%
United Therapeutics
May 6, 2026
Maintained: Buy
Price Target: $707 → $701
Current: $540.05
Upside: +29.80%
Viridian Therapeutics
May 6, 2026
Reiterated: Buy
Price Target: $30 → $34
Current: $15.87
Upside: +114.24%
Ocular Therapeutix
May 5, 2026
Maintained: Buy
Price Target: $30
Current: $8.31
Upside: +261.01%
Rhythm Pharmaceuticals
May 5, 2026
Maintained: Buy
Price Target: $136 → $137
Current: $84.35
Upside: +62.42%